Search results
Alzheimer’s Foundation of America encouraged by new drug closer to FDA approval
WBRC Fox 6 Birmingham· 3 days agoFederal health advisers are recommending a new Alzheimer’s drug from Eli Lilly that slows the...
Clear need to improve NHS screening for new Alzheimer’s drugs – study
Press Association News via AOL· 3 days agoThere is a “clear and urgent” need to improve NHS screening to work out who may benefit from new ...
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
Fox News via Yahoo News· 3 days agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration...
Can Alzheimer's really be reversed, as a new documentary claims?
Medical Xpress· 7 days agoDementia and Alzheimer's have been the leading killers in the UK for the last ten years, accounting...
FDA panel backs new Alzheimer's drug, Apple unveils new AI and iOS features and Warner Bros....
The Yodel via Yahoo News· 4 days agoGet caught up on this morning’s news: A new Alzheimer’s drug, the ‘Practical Magic’ sequel and more...
A Drug to Slow Alzheimer’s Is Finally Available. How Are Patients Faring?
New York Times· 5 days agoAs the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar ...
New Alzheimer’s treatment could bring hope to local families impacted by the disease
WPXI· 2 days agoAbout 280,000 people in Pennsylvania are living with a heart-wrenching disease called Alzheimer’s....
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 4 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 1 day agoAt the time, Lilly was bouncing back from a series of patent losses and drug-research failures. It...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 4 days agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...